Intervention: Serplulimab combined with bevacizumab and first-line chemotherapy
Found 4 matching trials
Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
This is an investigator-initiated, open-label, single-arm, phase II trial e...
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
PHASE2
This is a two-arm, randomized, double-blinded, multicenter phase III clinic...
Status
Recruiting
Location
Center for Cancer Prevention and Treatment of Sun Yat-sen University